RenovoRx, Inc. — Director's Dealing 2021

Aug 25, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: RenovoRx, Inc. (RNXT)
CIK: 0001574094
Period of Report: 2021-08-25

Reporting Person: Manners Paul (Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	23333	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$0.70	2030-02-04	Common Stock (4666)		Direct

Footnotes

F1: The shares subject to the option are fully vested.